AAAAAA

   
Results: 1-25 |
Results: 25
IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE
Authors: HAUBRICH R LALEZARI J FOLLANSBEE SE GILL MJ HIRSCH M RICHMAN D MILDVAN D BURGER HU BEATTIE D DONATACCI L SALGO MP
Citation: R. Haubrich et al., IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE, Antiviral therapy, 3(1), 1998, pp. 33-42
EVALUATION OF AN INTENSIVE INTERMITTENT-INDUCTION REGIMEN AND DURATION OF SHORT-COURSE TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS-RELATED PULMONARY TUBERCULOSIS
Authors: ELSADR WM PERLMAN DC MATTS JP NELSON ET COHN DL SALOMON N OLIBRICE M MEDARD F CHIRGWIN KD MILDVAN D JONES BE TELZAK EE KLEIN O HEIFETS L HAFNER R
Citation: Wm. Elsadr et al., EVALUATION OF AN INTENSIVE INTERMITTENT-INDUCTION REGIMEN AND DURATION OF SHORT-COURSE TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS-RELATED PULMONARY TUBERCULOSIS, Clinical infectious diseases, 26(5), 1998, pp. 1148-1158
AN APPROACH TO THE VALIDATION OF MARKERS FOR USE IN AIDS CLINICAL-TRIALS
Authors: MILDVAN D LANDAY A DEGRUTTOLA V MACHADO SG KAGAN J
Citation: D. Mildvan et al., AN APPROACH TO THE VALIDATION OF MARKERS FOR USE IN AIDS CLINICAL-TRIALS, Clinical infectious diseases, 24(5), 1997, pp. 764-774
COMPARATIVE IN-VITRO ACTIVITIES OF RP59500 (QUINUPRISTIN DALFOPRISTIN), CL-329,998, CL-331,002, TROVAFLOXACIN, CLINAFLOXACIN, TEICOPLANIN AND VANCOMYCIN AGAINST GRAM-POSITIVE BACTERIA/
Authors: SHONEKAN D HANDWERGER S MILDVAN D
Citation: D. Shonekan et al., COMPARATIVE IN-VITRO ACTIVITIES OF RP59500 (QUINUPRISTIN DALFOPRISTIN), CL-329,998, CL-331,002, TROVAFLOXACIN, CLINAFLOXACIN, TEICOPLANIN AND VANCOMYCIN AGAINST GRAM-POSITIVE BACTERIA/, Journal of antimicrobial chemotherapy, 39(3), 1997, pp. 405-409
CONCENTRATIONS OF SOLUBLE CD95 AND CD8 ANTIGENS IN THE PLASMA AND LEVELS OF CD8-CELLS ARE MARKERS FOR HIV-1 INFECTION AND CLINICAL STATUS(CD95+, CD8+CD38+, AND CD4+CD95+ T)
Authors: JIANG JD SCHLESINGER M SACKS H MILDVAN D ROBOZ JP BEKESI JG
Citation: Jd. Jiang et al., CONCENTRATIONS OF SOLUBLE CD95 AND CD8 ANTIGENS IN THE PLASMA AND LEVELS OF CD8-CELLS ARE MARKERS FOR HIV-1 INFECTION AND CLINICAL STATUS(CD95+, CD8+CD38+, AND CD4+CD95+ T), Journal of clinical immunology, 17(2), 1997, pp. 185-192
CLINICAL TREATMENT
Authors: MILDVAN D COOPER DA
Citation: D. Mildvan et Da. Cooper, CLINICAL TREATMENT, AIDS, 11, 1997, pp. 139-139
CLINICAL-FEATURES AND OUTCOME OF HIV-RELATED CYTOMEGALOVIRUS PNEUMONIA
Authors: SALOMON N GOMEZ T PERLMAN DC LAYA L EBER C MILDVAN D
Citation: N. Salomon et al., CLINICAL-FEATURES AND OUTCOME OF HIV-RELATED CYTOMEGALOVIRUS PNEUMONIA, AIDS, 11(3), 1997, pp. 319-324
TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: VANDERHORST CM SAAG MS CLOUD GA HAMILL RJ GRAYBILL JR SOBEL JD JOHNSON PC TUAZON CU KERKERING T MOSKOVITZ BL POWDERLY WG DISMUKES WE RISER L THOMAS C LACKE C WHITE AC PATTERSON S DAVIS D FLANIGAN C HARDEN T PHILLIPS D ULLOM I VASQUEZ J MCMULLEN S FLOWERS D BOSHA M BRITTON M FISHER JF NEWMAN C WILLIS B HENDERSON H JOHNSON E DUNGO L PIERCE M MORGAN M STERN J PETROSKY N BAMBERGER D FARNAN R FEINBERG J APUZZO L ROYAL W THOMPSON S BARRETT K KAUFFMAN C GUTSCH H MCKINSEY D LEE B HYSLOP N GREENSPAN D STRATA R FESSEL WJ VANRAALTE G PANKEY G SCHNEIDER D BRIGGS ND PIERCE D LEE S VANGNESS I LONGMIRE B STANSELL J JACOBSON M GRAY D COLEMAN R VOORHEES J KLEBERT M ROYAL M MILDVAN D FRIEDLAND G COONEY E WALESKY M LEEDOM JM LARSEN R DIAMOND D WHEAT LJ NIXON H CRAFT J NEIDIG JL FASS RJ RUSSELL J MACGREGOR RR KAPPES R TSELIS A SKAHAN KJ JACKSON B DANIEL P PAULSONWHITE C HEWITT R COHN S LEWIS M GREISBERGER C HELLER H SUGAR A KARCHMER AW FITCH H FLAM R JOSEPH M ELSADR W SOEIRO R STEIN D ZINGMAN B POLLARD R HAUSRATH S WATERMAN K SQUIRES K PONTICELLO L GRIECO M HAFNER R DIXON D
Citation: Cm. Vanderhorst et al., TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The New England journal of medicine, 337(1), 1997, pp. 15-21
WEIGHT-LOSS ASSOCIATED WITH HIV SEROCONVERSION AMONG INJECTION-DRUG USERS
Authors: MARMOR M TITUS S HARRISON C CORDCRUZ EA SHORE RE VOGLER M KRASINSKI K MILDVAN D JARLAIS DCD
Citation: M. Marmor et al., WEIGHT-LOSS ASSOCIATED WITH HIV SEROCONVERSION AMONG INJECTION-DRUG USERS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 514-518
A PHASE-II STUDY OF RECOMBINANT HUMAN INTERFERON-(ALPHA-2A) AND ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA
Authors: FISCHL MA FINKELSTEIN DM HE WL POWDERLY WG TRIOZZI PL STEIGBIGEL RT MAIEWSKI S DALE E MILLAR L GOULD M RATNER L PARA MF GOWER R TENZLER R FUHRER J MILDVAN D MALAMUD SC DEZUBE B CHAPMAN B CRUMPACKER C ISRAEL HB FEINBERG J HOOD A RAINES CP MILES SA MITSUYASU RT CARDEN J MCMAHON D PAZIN G SCHULOF RS CORTLESS JL LELACHEUR SF EHMANN WC EYSTER ME MCKINLEY GF GRIECO MH KOLATCH B BENNETT JM RYBAK ME CHEESEMAN SH KOUP RA DIAMOND A
Citation: Ma. Fischl et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERFERON-(ALPHA-2A) AND ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 379-384
CLINICAL-FEATURES AND OUTCOMES OF CYTOMEGALOVIRUS PNEUMONIA IN HIV-INFECTED PERSONS
Authors: GOMEZ TS SALOMON N LAYA L EBER C PERLMAN DC MILDVAN D
Citation: Ts. Gomez et al., CLINICAL-FEATURES AND OUTCOMES OF CYTOMEGALOVIRUS PNEUMONIA IN HIV-INFECTED PERSONS, Clinical infectious diseases, 23(4), 1996, pp. 244-244
AMPHOTERICIN-B LIPID COMPLEX COMPARED WITH AMPHOTERICIN-B IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS
Authors: SHARKEY PK GRAYBILL JR JOHNSON ES HAUSRATH SG POLLARD RB KOLOKATHIS A MILDVAN D FANHAVARD P ENG RHK PATTERSON TF POTTAGE JC SIMBERKOFF MS WOLF J MEYER RD GUPTA R LEE LW GORDON DS
Citation: Pk. Sharkey et al., AMPHOTERICIN-B LIPID COMPLEX COMPARED WITH AMPHOTERICIN-B IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(2), 1996, pp. 315-321
PREVALENCE OF HUMAN HERPESVIRUS-8 DNA-SEQUENCES IN SEVERAL PATIENT POPULATIONS
Authors: MARCHIOLI CC LOVE JL ABBOTT LZ HUANG YQ REMICK SC SURTENTOREODICA N HUTCHISON RE MILDVAN D FRIEDMANKIEN AE POIESZ BJ
Citation: Cc. Marchioli et al., PREVALENCE OF HUMAN HERPESVIRUS-8 DNA-SEQUENCES IN SEVERAL PATIENT POPULATIONS, Journal of clinical microbiology, 34(10), 1996, pp. 2635-2638
PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL
Authors: LEPORT C CHENE G MORLAT P LUFT BJ ROUSSEAU F PUEYO S HAFNER R MIRO J AUBERTIN J SALAMON R VILDE JL BLANC AP SCHMITT JL ARLAUD J ESTAVOYER JM GUILLEVIN L BENTATA M BEYLOT J LACUT JY GRANIER P COSNARD F BAZIN C DORMONT J REY M DELAUNAY C TROISVALLET D MICOUD M WEINBRECK P TREPO C GALLAIS H GASTAUT JA ALLARD C JANBON F CANTON P GROLLEAU JY CASSUTO J DELLAMONICA P DURET P FROTTIER J HERSON S SELIGMANN M SERENI D GIRAUDON BB DIEN G RUEL M STORCK D JAUBERT D LAFEUILLADE A MOUTON Y CHOUTET P LAFAIX C GATELL JM GUELAR A MILDVAN D SOIERO R JACOBSON JM MURRAY HW STEIGBIGEL NH SACHS HH VALENTINE F GRIECO MH ARMSTRONG D LEDERMAN M BARTLETT JA WASKIN HA NICHOLAS P FESSEL JW MACARTHUR RD GLATT AE PHAIR JP POWDERLY W HEWITT R STEIGBIGEL RT BLAIR DC SKAHAN KJ FRAME P CHEESEMAN SH CONNOR EM BALFOUR HH VANDERHORST C HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
PENTAMIDINE AEROSOL VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PNEUMOCYSTIS-CARINII IN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
Authors: MONTGOMERY AB FEIGAL DW SATTLER F MASON GR CATANZARO A EDISON R MARKOWITZ N JOHNSON E OGAWA S ROVZAR M UDEM SA EDEN E HYSLOP N CHEUNG TW KESSLER H MILDVAN D GIRON JA ETTINGER N CRUMPACKER C FRAME P STEIGBIGEL N VANDERHORST C HIRSCH M LEDERMAN MM HEWITT RG FALLAT R FARBER HW SACKS HS EISMAN SA LUCE JM BOYLAN T ADAMS M FEINBERG J HOPEWELL PC
Citation: Ab. Montgomery et al., PENTAMIDINE AEROSOL VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PNEUMOCYSTIS-CARINII IN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, American journal of respiratory and critical care medicine, 151(4), 1995, pp. 1068-1074
PREDICTORS AND OUTCOME OF MULTIDRUG-RESISTANT TUBERCULOSIS
Authors: SALOMON N PERLMAN DC FRIEDMANN P BUCHSTEIN S KREISWIRTH BN MILDVAN D
Citation: N. Salomon et al., PREDICTORS AND OUTCOME OF MULTIDRUG-RESISTANT TUBERCULOSIS, Clinical infectious diseases, 21(5), 1995, pp. 1245-1252
LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
Authors: GALLANT JE MOORE RD KERULY J RICHMAN DD CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T KESSLER H BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R CHAPMAN R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J LANE C TILSON H ANDREWS E SMILEY L
Citation: Je. Gallant et al., LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, The Journal of infectious diseases, 172(2), 1995, pp. 346-352
ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE
Authors: DOLIN R AMATO DA FISCHL MA PETTINELLI C BELTANGADY M LIOU SH BROWN MJ CROSS AP HIRSCH MS HARDY WD MILDVAN D BLAIR DC POWDERLY WG PARA MF FIFE KH STEIGBIGEL RT SMALDONE L CRUMPACKER CS COOLEY T MITSUYASO RT JOHN R SANDERS C REITMAN D HEWITT R REICHMAN RC GELB LD MCGUIRE ML JONES M NEIDIG JL ZWICKL B HARTMAN PB ROARKE ME BURK RA FUHRER J SOMOGYI KA SEPKOWITZ K TELZAK EE MCAULIFFE VJ VALENTINE FT VASQUEZ M MERIGAN TC KATZENSTEIN D FESSELL J HAVLIR DV RICHMAN DD SPECTOR SA KAHN JO JOHNSON L COLEMAN R HO M MCMAHON D PAZIN G ANTONISKIS D MCNAMARA B DIAMOND D COLLIER AC PARADISE MA WALD A DEPAOLISJONES A HENRY K WASKIN HA HYSLOP NE MUSHATT DM ZACHARY JA SOEIRO R HARRIS C ZINGMAN B GIORDANO MF SLEDZ S MURRAY HW CAREY JT DAVIS TL BAGBY B KESSLER HA MURPHY RL HIRSCHTICK RE CHEESEMAN SH LAI KK FAIRCHILD PG EHMANN WC ZURLO JJ MILLARD R TROIANI L HEGGEN AA VANDERHORST CM MCKINLEY GF GRIECO MH KOLATCH BR GOLDSMITH JC GOMPERTS ED WOODS LM GRUE L MAYJO K BECKER RL JAYAWEERA DT ROLFE L COLE J JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE
Authors: FISCHL MA STANLEY K COLLIER AC ARDUINO JM STEIN DS FEINBERG JE ALLAN JD GOLDSMITH JC POWDERLY WG RAINES CP MAYJO KJ KERULY JC CRAVEN D HIRSHORN L HIRSCH MS JAYAWEERA DT YOUNG SW PATRONEREESE J BRETTLER D SPERBER K GERITS P SEREMETIS S GILL JC GELB LD MCGUIRE ML STIFFLER T LEDERMAN MM CAREY JT WALLACE M MACARTHUR RD BERGE P MILDVAN D COREY L COOMBS RW CUMMINGS DK SCHOOLEY RT RAY MG WAITE V KURITZKES DR FUHRER J TENZLER RJ DONLON W VANDERHORST CM TROIANI L HORTON J LANE TW MURPHY RR PHAIR JP KESSLER HA BENSON CA ROSENWALD V YONREN S VALENTINE F HASLETT P MITSUYASU RT GUERRO M GOETZ MB MATHISEN GE FRAME PT BRINKDOPKE J POWELL T HOELLE M MERIGAN TC SHAFER R CAIN P FESSELL J HENRY K RHAME F CHRISTENSON J STRYKE D ZINGMAN B KAHL P SOEIRO R CHOI YS REICHMAN RL REID J BLAIR DC STEIGBIGEL RT HEWITT RG CAMERON ML DONNELLY MA PACKARD MV BARTLETT JA FIFE KH ZWICKL BW BORUM J BURACK JH DYBECK KA COLEMAN RL JOHNSON WR MCKINLEY GF GRIECO MH KOLATCH BR SEPKOWITZ K PONTICELLO L GIORDANO MF MURRAY HW GOCKE DJ FASS RJ PARA MF STERN JS DREW LJ SPECTOR SA HAVLIR DV NUFFER KL RICHMAN DD CONNOR EM KLOSER PC PICARDI JM VANMATERMINER C LEEDOM JM HOLTOM PD RICHARDSON W EHMANN WC ZURLO JJ KREHER M EYSTER ME HYSLOP NE MUSHATT DM HOADLEY DJ ZACHARY JA SIMON GL PARENTI DM LELACHEUR S SCHUCK S HO MT MCMAHON DK PAZIN GJ ROSENER R CHEESEMAN SH MANGINI LA SANDS MG KAZIAL K JONES G PETTINELLI CB LANDRY B MARTINEZ AI
Citation: Ma. Fischl et al., COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE, Annals of internal medicine, 122(1), 1995, pp. 24-32
PROPHYLACTIC ZALCITABINE AND INTERFERON-ALPHA FOR A LARGE-BORE NEEDLESTICK EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: MILDVAN D BERGE P STARRETT S STCLAIR M SALGO M
Citation: D. Mildvan et al., PROPHYLACTIC ZALCITABINE AND INTERFERON-ALPHA FOR A LARGE-BORE NEEDLESTICK EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of acquired immune deficiency syndromes, 7(4), 1994, pp. 416-417
CONTINUITY AND CHANGE WITHIN AN HIV EPIDEMIC - INJECTING DRUG-USERS IN NEW-YORK-CITY, 1984 THROUGH 1992
Authors: JARLAIS DCD FRIEDMAN SR SOTHERAN JL WENSTON J MARMOR M YANCOVITZ SR FRANK B BEATRICE S MILDVAN D
Citation: Dcd. Jarlais et al., CONTINUITY AND CHANGE WITHIN AN HIV EPIDEMIC - INJECTING DRUG-USERS IN NEW-YORK-CITY, 1984 THROUGH 1992, JAMA, the journal of the American Medical Association, 271(2), 1994, pp. 121-127
RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
Authors: GALLANT JE MOORE RD RICHMAN DD KERULY J CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J TILSON H SMILEY L
Citation: Je. Gallant et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, Archives of internal medicine, 154(5), 1994, pp. 566-572
ORAL ATOVAQUONE COMPARED WITH INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS
Authors: DOHN MN WEINBERG WG TORRES RA FOLLANSBEE SE CALDWELL PT SCOTT JD GATHE JC HAGHIGHAT DP SAMPSON JH SPOTKOV J DERESINSKI SC MEYER RD LANCASTER DJ FRAME PT MOHSENIFAR Z BUCKLEY RM CHEUNG T HYLAND R CHAN C LANG W MILDVAN D GREENBERG SB CRAVEN D HIRSCH M ELSADR W JOSEPH P HARDY D BROWN N ROGERS M
Citation: Mn. Dohn et al., ORAL ATOVAQUONE COMPARED WITH INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS, Annals of internal medicine, 121(3), 1994, pp. 174-180
CD4 LYMPHOCYTOPENIA AMONG INJECTING DRUG-USERS IN NEW-YORK-CITY
Authors: JARLAIS DCD FRIEDMAN SR MARMOR M MILDVAN D YANCOVITZ S SOTHERAN JL WENSTON J BEATRICE S
Citation: Dcd. Jarlais et al., CD4 LYMPHOCYTOPENIA AMONG INJECTING DRUG-USERS IN NEW-YORK-CITY, Journal of acquired immune deficiency syndromes, 6(7), 1993, pp. 820-822
THE ROLE OF INTERFERON IN HIV DISEASE
Authors: MILDVAN D
Citation: D. Mildvan, THE ROLE OF INTERFERON IN HIV DISEASE, Journal of cellular biochemistry, 1993, pp. 19-19
Risultati: 1-25 |